Cargando…
Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model
BACKGROUND: The medical treatment of periprosthetic joint infection (PJI) involves prolonged systemic antibiotic courses, often with suboptimal clinical outcomes including increased morbidity and health-care costs. Oral and intravenous monotherapies and combination antibiotic regimens were evaluated...
Autores principales: | Thompson, John M., Saini, Vikram, Ashbaugh, Alyssa G., Miller, Robert J., Ordonez, Alvaro A., Ortines, Roger V., Wang, Yu, Sterling, Robert S., Jain, Sanjay K., Miller, Lloyd S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Journal of Bone and Joint Surgery, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181281/ https://www.ncbi.nlm.nih.gov/pubmed/28419033 http://dx.doi.org/10.2106/JBJS.16.01002 |
Ejemplares similares
-
Animal experimental investigation on the efficacy of antibiotic therapy with linezolid, vancomycin, cotrimoxazole, and rifampin in treatment of periprosthetic knee joint infections by MRSA
por: Goetz, Julia, et al.
Publicado: (2022) -
Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
por: Darwich, Ali, et al.
Publicado: (2021) -
Clinical use of linezolid in periprosthetic joint infections – a systematic review
por: Theil, Christoph, et al.
Publicado: (2020) -
Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
por: Leijtens, Borg, et al.
Publicado: (2017) -
In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2021)